Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile: a

Sumit Raybardhan1, Bradley Langford2, Russell Forrest1

  • 1University of Toronto Dalla Lana School of Public Health, Canada.

Abstract

Insights

Antimicrobial use in institutions may increase the risk of antimicrobial resistance (AMR) and Clostridioides difficile infections in unexposed individuals. This systematic review highlights collateral risks, emphasizing the need for further research.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Epidemiology

Background:

  • Antimicrobial use (AMU) within healthcare settings can lead to the development of antimicrobial resistance (AMR) and infections like Clostridioides difficile.
  • Understanding the indirect effects, or spillover effects, of AMU on unexposed individuals is crucial for infection control.

Purpose of the Study:

  • To synthesize existing evidence on the institutional spillover effects of AMU on AMR and C. difficile infections in individuals not directly exposed to antimicrobials.

Main Methods:

  • A systematic review was conducted, searching three databases through August 2024.
  • Five observational studies were included, analyzing data from hospital wards and nursing homes.
  • A hybrid synthesis approach, including meta-analysis, was used, adhering to PRISMA guidelines.

Main Results:

  • Low to moderate quality evidence suggests a positive spillover effect: increased facility AMU is associated with higher collateral risks.
  • Meta-analysis of three studies indicated a pooled IRR of 1.54 (95% CI 0.85-2.80) per 100 days of therapy per 1,000 patient-days, with significant heterogeneity.

Conclusions:

  • Institutional AMU is associated with increased risks of AMR and C. difficile in unexposed individuals.
  • Methodological limitations and potential bias necessitate further research with standardized terminology and robust designs to clarify spillover mechanisms.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
130
Antibiotic Selection00:57

Antibiotic Selection

Overview
48.9K